Fennec Pharmaceuticals, Inc. (FENC)
8.74
-0.04
(-0.46%)
USD |
NASDAQ |
Feb 20, 16:00
8.71
-0.03
(-0.34%)
After-Hours: 20:00
Fennec Pharmaceuticals EPS Diluted (Quarterly) : -0.0229 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.638M |
| Revenue (Quarterly) | 12.46M |
| Total Expenses (Quarterly) | 13.10M |
| Enterprise Value | 294.66M |
| Gross Profit Margin (Quarterly) | 94.70% |
| Profit Margin (Quarterly) | -5.12% |
| Earnings Yield | -2.72% |
| Normalized Earnings Yield | -2.704 |